EC Number | Application | Comment | Organism |
---|---|---|---|
3.1.1.4 | drug development | targeted inhibition of PLA2- and autotaxin-mediated lysophosphatidic acid synthesis may be a potential strategy for the prevention of nerve injury-induced neuropathic pain | Mus musculus |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.1.4.39 | expressed in B-103 cells | Mus musculus |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.1.1.4 | arachidonyl trifluoromethyl ketone | AACOCF3, both de novo lysophosphatidic acid production and neuropathic pain-like behaviors are substantially abolished by intrathecal injection of arachidonyl trifluoromethyl ketone, a mixed inhibitor of cPLA2 and iPLA2, at 1 h after injury | Mus musculus | |
3.1.1.4 | bromoenol lactone | both de novo lysophosphatidic acid production and neuropathic pain-like behaviors are substantially abolished by intrathecal injection of bromoenol lactone, an iPLA2 inhibitor, at 1 h after injury | Mus musculus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.4.39 | lysophosphatidylcholine + H2O | Mus musculus | - |
lysophosphatidic acid + choline | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.1.1.4 | Mus musculus | - |
male C57BL/6J mice | - |
3.1.4.39 | Mus musculus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.1.1.4 | spinal cord | - |
Mus musculus | - |
3.1.4.39 | spinal cord | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.1.1.4 | arachidonyl thio-PC + H2O | - |
Mus musculus | arachidonic acid + (7R)-4-hydroxy-N,N,N-trimethyl-7-sulfanyl-3,5,9-trioxa-4-phosphapentacosan-1-aminium 4-oxide | - |
? | |
3.1.4.39 | lysophosphatidylcholine + H2O | - |
Mus musculus | lysophosphatidic acid + choline | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.1.1.4 | calcium-independent phospholipase A2 | - |
Mus musculus |
3.1.1.4 | cPLA2 | - |
Mus musculus |
3.1.1.4 | cytosolic phospholipase A2 | - |
Mus musculus |
3.1.1.4 | iPLA2 | - |
Mus musculus |
3.1.4.39 | ATX | - |
Mus musculus |
3.1.4.39 | autotaxin | - |
Mus musculus |
EC Number | Organism | Comment | Expression |
---|---|---|---|
3.1.4.39 | Mus musculus | the concentration and enzyme activity of ATX are not affected by nerve injury | additional information |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.1.1.4 | physiological function | PLA2- and autotaxin-mediated de novo lysophosphatidic acid production in the early phase is involved in nerve injury-induced neuropathic pain | Mus musculus |